Unlocking R&D performance for pharma and biotech with faster, smarter, and more efficient development.
Pharmaceutical and Life Sciences R&D Operations
Overview
We don't observe how R&D is changing. We’ve built the delivery models behind the shift. Our team has led the industry in retail-based and health-system clinical trial models, deployed AI-based clinical trial oversight, and next-generation resource forecasting and reporting. We bring an operator's perspective to modernizing R&D across ClinOps, medical affairs, and clinical data and portfolio management, all to help expand patient access, accelerate new medicines, and lower the cost to market.
Market trends
Capabilities
- Portfolio operations and governance
- Clinical development & clinical operations as a service
- Medical affairs of the future
- Clinical trial technology & AI-enabled trials
- R&D asset management
Portfolio operations and governance
Make better portfolio bets faster and with more confidence. We establish proactive decisions and real-time monitoring through PPM strategy and operations, portfolio governance and prioritization, resource and financial management, and R&D systems strategy and implementation.
Clinical development & clinical operations as a service
Clinical operations leaders are asked to run more trials, faster, without adding budget or risk. With many team members as former ClinOps and trial operations practitioners we design for the constraints you actually face. Our industry-leading solutions for protocol optimization, digital trial core, monitoring platform comprise our clinical operations as a service model where we compress study start-up well below industry standards.
Medical affairs of the future
Jumpstart launch readiness and strengthen post-approval performance. We embed real-world data and evidence generation across the value chain, enhance stakeholder engagement through omnichannel KOL and MSL strategies, and deliver medical launch excellence with strategic planning for successful product launches.
Clinical trial technology & AI-enabled trials
Only ~2% of the population has access to traditional clinical trials. We've spent years changing that, building pharmacy retail and AMC-based clinical trial businesses from the ground up, standing up site management organizations, and deploying risk-based quality management and AI-enabled delivery. Our team is now on a journey to architect next-generation trial platforms that reach patients where they are.
R&D asset management
Unlock asset value and strategic optionality throughout the R&D lifecycle. We enhance portfolio strategy, asset governance, and transaction readiness through asset strategy and study cutover planning, transaction playbook and operating model development, and post-deal portfolio integration.
Insights
Case studies
